DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

RecruitingOBSERVATIONAL
Enrollment

13,600

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2026

Conditions
Ovarian Neoplasms
Interventions
OTHER

Blood test: CA-125 biomarker

"* CA-125 biomarker blood test at visit 1, day 1.~* CA-125 biomarker blood test at visit 2, week 6."

OTHER

Second Test: Transvaginal Ultrasound

-Transvaginal Ultrasound at visit 1, day 1.

OTHER

Follow-up phone call

Phone call 6 months after last visit to verify continued health.

Trial Locations (8)

H9H0C4

ACTIVE_NOT_RECRUITING

West Island Cancer Wellness Centre, Kirkland

H7V2S8

ACTIVE_NOT_RECRUITING

Axion 50 plus, Laval

H1H 1J6

WITHDRAWN

Clinique Familiale Pas-A-Pas, Montreal

H1M 3M4

ACTIVE_NOT_RECRUITING

Clinique Médicale du Haut-Anjou, Montreal

H4A 3J1

RECRUITING

McGill University Health Centre, Royal Victoria Hospital, Montreal

H4A 3L6

RECRUITING

Queen Elizabeth Health Centre, Montreal

H8S 3N5

ACTIVE_NOT_RECRUITING

Lachine Hospital, Montreal

J4P 2K7

ACTIVE_NOT_RECRUITING

Clinique du Dr. L. Quintal, Saint-Lambert

All Listed Sponsors
lead

McGill University

OTHER